LGND
Ligand Pharmaceuticals
NASDAQ · Pharmaceuticals
$190.44
-1.25 (-0.65%)
Performance
1D
—
1W
-3.78%
1M
-7.92%
3M
-8.75%
6M
+22.07%
1Y
+66.88%
YTD
+0.17%
Open$194.61
Previous Close$191.69
Day High$197.00
Day Low$189.17
52W High$212.49
52W Low$93.58
Volume272.8K
Avg Volume181.5K
Market Cap3.75B
P/E Ratio77.15
EPS$2.08
SectorPharmaceuticals
Volume Analysis
1.50x average volume
Technical Indicators
SMA 50
$195.11
Below
SMA 200
$158.99
Above
RSI (14)
47.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-83.4% upside
Current
$190.44
$190.44
Target
$31.56
$31.56
$18.80
$31.56 avg
$35.41
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 179.85M | 212.86M | 1.00B |
| Net Income | -4,337,851 | -4,620,743 | 235.57M |
| Profit Margin | -2.4% | -2.3% | 23.5% |
| EBITDA | -31,754,489 | -35,704,538 | 340.17M |
| Free Cash Flow | — | — | 240.43M |
| Rev Growth | -15.5% | -15.5% | -5.7% |
| Debt/Equity | — | — | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |